Mayne says it’s not on hook for break fee over failed Cosette merger
Healthcare 2025-12-11 2:56 pm By Cat Fredenburgh
Please login to bookmark Close

Mayne Pharma says it, and not US drug maker Cosette, has terminated their $672 merger agreement and that it is therefore not on the hook for a break fee.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au